🇺🇸 FDA
Patent

US 9556244

Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

granted A61KA61K2039/53A61K2039/552

Quick answer

US patent 9556244 (Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/53, A61K2039/552, A61K2039/55566, A61K39/0003